Advertisement
Research ArticleDrug Discovery and Translational Medicine

LLY-2707, A Novel Nonsteroidal Glucocorticoid Antagonist That Reduces Atypical Antipsychotic–Associated Weight Gain in Rats

Dana K. Sindelar, Mathew W. Carson, Michelle Morin, Janice Shaw, Robert J. Barr, Anne Need, Jesline Alexander-Chacko, Michael Coghlan and Donald R. Gehlert
Journal of Pharmacology and Experimental Therapeutics January 2014, 348 (1) 192-201; DOI: https://doi.org/10.1124/jpet.113.205864

Article Information

vol. 348 no. 1 192-201
DOI 
https://doi.org/10.1124/jpet.113.205864
PubMed 
24163440
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online December 16, 2013.

Article Versions

Copyright & Usage 
Copyright © 2013 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Dana K. Sindelar,
  2. Mathew W. Carson,
  3. Michelle Morin,
  4. Janice Shaw,
  5. Robert J. Barr,
  6. Anne Need,
  7. Jesline Alexander-Chacko,
  8. Michael Coghlan, and
  9. Donald R. Gehlert
  1. Neuroscience and Endocrine Divisions, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana
  1. Address correspondence to:
    Dr. Donald R. Gehlert, Mail Code 0510, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285. E-mail: gehlert_donald_r{at}lilly.com.
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: October 2013 to March 2023

AbstractFullPdf
Oct 2013140042
Nov 20131660112
Dec 2013269849
Jan 2014152935
Feb 20141031043
Mar 2014811228
Apr 2014831430
May 201451626
Jun 201455721
Jul 201448714
Aug 201439711
Sep 20142368
Oct 2014481111
Nov 20142949
Dec 2014261513
Jan 2015372325
Feb 2015302113
Mar 2015212213
Apr 2015241014
May 2015191524
Jun 201581111
Jul 2015181416
Aug 2015101313
Sep 2015371722
Oct 201592413
Nov 2015291320
Dec 2015132611
Jan 2016262132
Feb 201692531
Mar 2016132531
Apr 2016172218
May 201681516
Jun 2016202027
Jul 2016171528
Aug 2016202423
Sep 2016121021
Oct 201641415
Nov 20164249
Dec 201611110
Jan 20170288
Feb 20172237
Mar 20173487
Apr 201711810
May 20171145
Jun 20173143
Jul 20170168
Aug 201724022
Sep 201711840
Oct 201752011
Nov 201733010
Dec 20171155
Jan 201833514
Feb 20183288
Mar 201813513
Apr 201833115
May 201802811
Jun 201813112
Jul 20180139
Aug 20180259
Sep 201811523
Oct 201822212
Nov 201802016
Dec 201891017
Jan 20191927
Feb 201919410
Mar 201913214
Apr 201914216
May 20191954
Jun 2019417
Jul 201918011
Aug 201910219
Sep 20192747
Oct 20191504
Nov 20191923
Dec 201928813
Jan 20202102
Feb 20203024
Mar 2020811
Apr 20202311
May 2020513
Jun 20202213
Jul 20202415
Aug 20201413
Sep 2020928
Oct 20201412
Nov 202050410
Dec 20202021
Jan 20212139
Feb 20211433
Mar 20213214
Apr 20212944
May 20211233
Jun 20211220
Jul 20212139
Aug 2021922
Sep 20211927
Oct 20211725
Nov 20211845
Dec 20212711
Jan 202219314
Feb 20222015
Mar 202225312
Apr 20221116
May 20221125
Jun 202228110
Jul 20222111
Aug 20223338
Sep 202225110
Oct 20221823
Nov 202213112
Dec 20221624
Jan 20232733
Feb 20231912
Mar 20232438

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleDrug Discovery and Translational Medicine

Glucocorticoid Receptor Antagonism and the HPAA

Dana K. Sindelar, Mathew W. Carson, Michelle Morin, Janice Shaw, Robert J. Barr, Anne Need, Jesline Alexander-Chacko, Michael Coghlan and Donald R. Gehlert
Journal of Pharmacology and Experimental Therapeutics January 1, 2014, 348 (1) 192-201; DOI: https://doi.org/10.1124/jpet.113.205864
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement